investor login
contact
team
dedicated funds
news
portfolio
Discover the
Latest
browse by categories
hatteras venture partner news
Portfolio Company News
Hatteras blogs
browse by categories
Search for:
Portfolio Company News
Medfusion Named Inaugural Member of GE Healthcare Centricity Partner Program
October 4, 2016
Tumor Ablation Expert Dr. Fred Lee, Jr. Joins HistoSonics as Board Member, Senior Medical Advisor
September 14, 2016
Spyryx Biosciences Expands Executive Team, Appoints Pulmonary Industry Leader, Alistair Wheeler, MD, MFPM as Chief Medical Officer
August 23, 2016
Clearside Biomedical, Inc. Announces Patient Treatment Comparison from the Phase 2 Trial (TANZANITE) in Patients with Macular Edema Associated with Retinal Vein Occlusion
July 27, 2016
Graybug Vision Expands Executive Team with Appointments of Charles P. Semba, MD, and Ward M. Peterson, PhD
June 22, 2016
Clearside Biomedical, Inc. Announces Pricing of Initial Public Offering
June 2, 2016
G1 Therapeutics Secures $47 Million Series C Financing
May 11, 2016
Graybug Vision Announces $44.5 Million Series B Financing
May 6, 2016
Just Download It: Wyoming Discovers Novel Way to Help Pregnant Mothers
May 6, 2016
Clearside Biomedical, Inc. Announces Positive Preliminary Phase 2 Results in Patients with Macular Edema Associated with Retinal Vein Occlusion
April 26, 2016
Bivarus Raises $2 Million to Fuel Expansion Following Strong Growth in 2015
March 24, 2016
Medfusion Announces Latest Version of Medfusion Plus at HIMSS16
March 2, 2016
Improving Odds for Women in Tech? Take Notes from Biotech
February 5, 2016
Clearside Biomedical, Inc. Announces Positive Topline Data from Phase 2 Clinical Trial for the Treatment of Macular Edema Associated with Non-Infectious Uveitis
January 8, 2016
ORIG3N™ Closes $12.5 Million in Funding Lead by Hatteras Venture Partners and Syno Capital
December 17, 2015
Clearside Biomedical, Inc. Completes $20 Million Series C Financing
December 17, 2015
5 Mission-Driven Companies That Are Changing The World
December 4, 2015
Startup Qvella gets $20M Series A to develop rapid pathogen detection test
October 29, 2015
Patient engagement platform Medfusion reels in $3 million
September 1, 2015
G1 Therapeutics Announces Initiation of Two Phase 1b/2a Trials of CDK4/6 Inhibitor G1T28 in Small-Cell Lung Cancer
August 11, 2015
Aerie Pharmaceuticals and GrayBug Announce Research Collaboration Focused on Novel Delivery Technologies for Aerie Product Candidates
August 6, 2015
Wildflower Health secures $5 million in financing to expand mobile, enterprise platform for maternity and family health
June 30, 2015
ORIG3N™ Announces Strategic Collaboration with LabCorp
May 19, 2015
NuSirt Biopharma Raises $6 Million in Series C Funding
May 18, 2015
Spyryx Biosciences Secures $18 Million in Series A Financing
May 7, 2015
Clearside Biomedical, Inc. and Santen, Inc. Announce Research Collaboration in Glaucoma
May 4, 2015
Spark Therapeutics and Clearside Biomedical Announce Exclusive Option to License Technology for Potentially Differentiated Delivery of Gene Therapy to the Eye
April 29, 2015
Contego Medical Closes $5.6 Million in Series B Funding
April 20, 2015
GrayBug to Participate in 7th Ocular Diseases Drug Discovery Conference
March 17, 2015
PhaseBio Raises $40 Million Series C Financing Led By AstraZeneca
March 12, 2015
GrayBug Raises $1.74 Million in Series A2 Financing
March 10, 2015
ORIG3N™ Closes $3.1 Million in Funding Lead by Hatteras Venture Partners
February 13, 2015
Lysosomal Therapeutics Inc. Raises $20 Million in Series A Financing
February 9, 2015
G1 Therapeutics Raises $33 Million in Series B Financing
February 5, 2015
G1 Therapeutics to Present at 17th Annual BIO CEO & Investor Conference
February 2, 2015
Clearside Biomedical, Inc. Announces Ongoing Results in Phase 1/2 Clinical Trial in Patients with Non-infectious Uveitis
October 15, 2014
Clearside Biomedical, Inc. Completes $16 Million Series B Financing
September 18, 2014
G1 Therapeutics Initiates Phase 1 Clinical Trial of G1T28-1
September 18, 2014
Clearside Biomedical, Inc. Completes $16 Million Series B Financing
September 4, 2014
Edison Partners Announces Investment in Clinverse, Inc.
August 19, 2014
G1 Therapeutics Completes Leadership Team with Appointment of Raj Malik, MD, Chief Medical Officer and Greg Mossinghoff, Chief Business Officer
June 17, 2014
G1 Therapeutics Appoints Dr. Mark Velleca as Chief Executive Officer
May 20, 2014
Lysosomal Therapeutics Inc. Receives $4.8 Million in Seed Funding
May 14, 2014
Clinipace becomes a ‘preferred provider,’ starts acting like a big CRO
April 21, 2014
Clinipace Worldwide Expands into Asia with Acquisition of Choice Pharma
March 12, 2014
Industry veteran and oncologist Dr. Seth Rudnick joins G1 Therapeutics as Executive Chairman
January 7, 2014
Harvard-Spun Curoverse Raises $1.5M to Build Biomedical Big Data Platform
December 19, 2013
G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum
November 14, 2013
G1 Therapeutics Raises $12.5M Series A Financing Led by MedImmune Ventures
October 16, 2013
Molecular diagnostics company GeneCentric collects $2.5 million for cancer tests
July 12, 2013
Santen Pharmaceuticals and Clearside Biomedical Announce Financing and Research Collaboration for Posterior Ocular Disease
January 31, 2013
SBA Licenses First Fund In Early Stage Capital Initiative
January 7, 2013
Clearside Biomedical Announces First Successful Human Dosing in a Safety and Tolerability Study in Patients with Retinal Disease
November 6, 2012
Coferon, Inc. Announces $12 Million Series B Financing
July 16, 2012
Clinverse Receives $3.8 Million to Expand Its Financial Technology for Clinical Trials
May 7, 2012
Clearside Biomedical Launched With Pipeline and Technology Focused on Drugs Delivered to the Back of the Eye
January 5, 2012
PhaseBio Pharmaceuticals Announces Positive Clinical Results with its Once Weekly GLP-1 analogue, Glymera for the Treatment of Hyperglycemia in Patients with Type 2 Diabetes
November 15, 2011
Morgan Stanley Expansion Capital Leads Series C Funding in Clinipace Worldwide
September 27, 2011
PerkinElmer Signs Agreement to Acquire CambridgeSoft Corporation and Completes Purchase of ArtusLabs, Inc.
March 24, 2011
Edwards Lifesciences Acquires Embrella Cardiovascular, Inc.
March 11, 2011
Viamet Pharmaceuticals, Dow AgroSciences to Collaborate on Development of Improved Crop Protection Products
November 2, 2010
Boston Scientific to Acquire Asthmatx
September 20, 2010
Inc. Magazine Names Clinipace Worldwide to the Inc. 500 Annual List of America’s Fastest-Growing Private Companies
August 24, 2010
Viamet, Novartis Fund Targeting Metalloenzymes in $200M Deal
February 23, 2010
HistoSonics, Inc. Announces Series A Financing
January 4, 2010
Clinipace Acquires Worldwide Clinical Research, Inc. – Company Expands to Enhance its Global Clinical Operations Capabilities and Therapeutic Practice Areas
November 9, 2009
Creating A Medical Device On The (Relatively) Cheap
August 31, 2009
Embrella Cardiovascular, Inc. Announces Final Closing of Series B Round
August 14, 2009
SpineAlign Medical Treats First Patient in U.S. with New, Innovative System for Vertebral Compression Fracture Repair
July 23, 2009
Viamet Pharmaceuticals Secures $18M Financing
July 7, 2009
Pathfinder Hires Medical Device Veteran as CEO
March 11, 2009
Pathfinder Lands $5 Million Series A Round
October 30, 2008
Craig Rosen, Biopharmaceutical Development Expert, Joins Phase Bioscience as Executive Chairman
October 9, 2008
SpineWorks Medical, Inc. Announces CE-Mark for SpineAlign Vertebral Body Replacement System
July 15, 2008
Leading Protein Engineering Executive Joins Phase Bioscience as CEO
April 15, 2008
Clinipace Raises $2.6 Million Series B
January 17, 2008
Phase Bioscience Announces Series B Investment from Johnson & Johnson Development Corporation, Fletcher Spaght Ventures and Hatteras Venture Partners
October 24, 2007
Viamet Pharmaceuticals Raises $4 Million Round of Financing
June 7, 2007
< Newer Posts
contact
team
dedicated funds
news
home
portfolio
